GC36194
GSK-626616
Also known as (5Z)-2-(2,6-dichlorophenyl)imino-5-(quinoxalin-6-ylmethylidene)-1,3-thiazolidin-4-one
GSK-626616 is a potent, orally bioavailable inhibitor of DYRK3 (IC50=0·7 nM)
ChemicalCAS1025821-33-3MW401.27FormulaC18H10Cl2N4OS
- CAS number
- 1025821-33-3
- Molecular weight
- 401.27
- Formula
- C18H10Cl2N4OS
- Solubility
- DMSO： 50 mg/mL (124·60 mM)
- InChIKey
- RJPNRXFBYZVRIB-DHDCSXOGSA-N
- Catalogue number
- GC36194
- Brand
- GLPBIO
Computed properties PubChem CID 135416229 · XLogP 4.6 · TPSA 92.5 Ų · H-bond donors 1
- XLogP
- 4.6
- TPSA
- 92.5 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Rotatable bonds
- 2
- Heavy atoms
- 26
SMILES C1=CC(=C(C(=C1)Cl)N=C2NC(=O)/C(=C/C3=CC4=NC=CN=C4C=C3)/S2)Cl
Computed descriptors from PubChem (CID 135416229), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il